GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per ...
SAN FRANCISCO — Surescripts is teaming up with Good Rx to surface key prescription discounts to consumers. The health information network announced Tuesday at the J.P. Morgan Healthcare Conference ...
Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence Surescripts®, the nation’s leading health ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...
Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to ...
Consumers can soon go to GoodRx (GDRX) for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation “We’re excited to help consumers access one of ...